Suspected Post-Chemotherapy Cardiomyopathy Hiding Severe Three-Vessel Coronary Artery Disease in a Young Patient with Metabolic Syndrome: Should an Early Angiography be Recommended?

Suspected Post-Chemotherapy Cardiomyopathy Hiding Severe Three-Vessel Coronary Artery Disease in a Young Patient with Metabolic Syndrome: Should an Early Angiography be Recommended?

Show other versions (1)

Cardiotoxicity is one of the most important adverse event related to anthracycline therapy and can lead in about 1-5% of cases to the occurrence of heart failure. In a higher percentage of patients treated with these drugs asymptomatic left ventricular dysfunction can occur, so that guidelines recom...

Full description

Bibliographic Details
Main Authors: Emanuele Cecchi, Raffaella Calabretta, Alessio Mattesini, Gian Franco Gensini, Cristina Giglioli
Format: Article
Language:English
Published: Tehran University of Medical Sciences 2012-10-01
Series:Acta Medica Iranica
Subjects:
Post-chemotherapy cardiomyopathy
Metabolic syndrome
Coronary angiography
Online Access:https://acta.tums.ac.ir/index.php/acta/article/view/3978

Internet

https://acta.tums.ac.ir/index.php/acta/article/view/3978

Similar Items